codecrusher101
@8ybig
Looking ahead to 2025 and 2026, keep an eye on these top four medications: Novo Nordisk leads with promising treatments for type 2 diabetes and obesity. Bristol Myers Squibb makes strides in schizophrenia care with their latest offering. Lilly introduces a new approach to tackling dermatitis. Finally, Sanofi's innovation in hemophilia management rounds up the list. Exciting times for healthcare!
0 reply
0 recast
0 reaction